Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
AstraZeneca
AstraZeneca
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Bristol-Myers Squibb
Medical College of Wisconsin
Incyte Corporation
Incyte Corporation
Janssen Research & Development, LLC
University of California, Irvine
Bristol-Myers Squibb
Sun Yat-sen University
Hoffmann-La Roche
Centre Leon Berard
Northwell Health